Neuropsychological rehabilitation for brain cancer survivors
Contextualized Neuropsychological Rehabilitation for CNS Cancer Survivors: The "I'm Aware: Patients and Carers Together" (ImPACT) Program"
NA · Aarhus University Hospital · NCT05858359
This study tests a new brain rehabilitation program for brain cancer survivors to see if it helps them improve their thinking skills and daily life.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Aarhus University Hospital (other) |
| Locations | 1 site (Aarhus) |
| Trial ID | NCT05858359 on ClinicalTrials.gov |
What this trial studies
This randomized-controlled study evaluates the feasibility, acceptability, and preliminary efficacy of the ImPACT program, a novel neuropsychological rehabilitation intervention designed for brain cancer survivors experiencing cognitive impairment. The program addresses key elements often missing in previous interventions, such as real-world functional outcomes, awareness training, involvement of carers, and the interconnectedness of cognitive and psychological functions. The study aims to prepare for a larger-scale trial by assessing how well this program can be integrated into the lives of patients and their carers.
Who should consider this trial
Good fit: Ideal candidates are brain cancer survivors who have completed primary treatment at least 6 months ago and are living with a carer who can participate.
Not a fit: Patients with confounding psychiatric or medical conditions unrelated to their cancer or its treatment may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve cognitive function and quality of life for brain cancer survivors.
How similar studies have performed: While there is limited research on interventions for cognitive impairment in brain cancer survivors, the novel approach of the ImPACT program addresses previously identified gaps, making it a potentially promising intervention.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of brain cancer * Completed primary treatment at least 6 months ago * Medically stable * Speaks and understand Danish * Living with a carer aged 18 or over, who also speaks and understands Danish and consents to participate in the study alongside the patient Exclusion Criteria: • Confounding diagnosed or suspected psychiatric or medical condition unrelated to the cancer or its treatment
Where this trial is running
Aarhus
- Aarhus University Hospital — Aarhus, Denmark (RECRUITING)
Study contacts
- Principal investigator: Lisa M Wu, PhD — Aarhus University Hospital
- Study coordinator: Lisa M Wu, PhD
- Email: lisa.wu@oncology.au.dk
- Phone: +45 87 15 37 48
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Brain Cancer, Cognitive Impairment, Brain Tumor, Neurobehavioral Impairment, Neuropsychological Rehabilitation